Brian M. J. Foxwell

Brian M. J. Foxwell publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brian M. J. Foxwell sits on this spectrum.

Brian M. J. Foxwell D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian M. J. Foxwell sits on this spectrum.

Overview

Best Publications

• Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

  Kim Midwood;Sandra Sacre;Anna M Piccinini;Julia Inglis

  805
  Citations

• Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline.

  Niccolò Terrando;Claudia Monaco;Daqing Ma;Brian M. J. Foxwell

  801
  Citations

• Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis

  Jared M. Huston;Mahendar Ochani;Mauricio Rosas-Ballina;Hong Liao

  782
  Citations

• Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

  Claudia Monaco;Evangelos Andreakos;Serafim Kiriakidis;Claudia Mauri

  525
  Citations

• Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease

  Andrew M. Smith;Farooq Z. Rahman;Bu'Hussain Hayee;Simon J. Graham

  508
  Citations

• Signalling, inflammation and arthritis NF-κB and its relevance to arthritis and inflammation

  R. E. Simmonds;B. M. Foxwell

  507
  Citations

• Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.

  Andrew D. Foey;Sarah L. Parry;Lynn M. Williams;Marc Feldmann

  482
  Citations

• Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages

  Lynn Williams;Laura Bradley;Alexandra Smith;Brian Foxwell

  478
  Citations

• The Pyridinyl Imidazole Inhibitor SB203580 Blocks Phosphoinositide-dependent Protein Kinase Activity, Protein Kinase B Phosphorylation, and Retinoblastoma Hyperphosphorylation in Interleukin-2-stimulated T Cells Independently of p38 Mitogen-activated Protein Kinase

  Ferdinand V. Lali;Abigail E. Hunt;Sarah J. Turner;Brian M.J. Foxwell

  442
  Citations

• Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

  David A van Heel;Subrata Ghosh;Matt Butler;Karen A Hunt

  392
  Citations

• Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent.

  B Foxwell;K Browne;J Bondeson;C Clarke

  379
  Citations

• Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.

  Satomichi Yoshimura;Jan Bondeson;Brian M. J. Foxwell;Fionula M. Brennan

  360
  Citations

• VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2

  Serafim Kiriakidis;Evangelos Andreakos;Claudia Monaco;Brian Foxwell

  331
  Citations

• The role of toll-like receptors in chronic inflammation.

  Stefan K. Drexler;Brian M. Foxwell

  322
  Citations

• Interleukin-10 suppression of myeloid cell activation — a continuing puzzle

  Lynn M Williams;Giuseppe Ricchetti;Usha Sarma;Timothy Smallie

  313
  Citations

• T Cell Proliferation in Response to Interleukins 2 and 7 Requires p38MAP Kinase Activation

  James B. Crawley;Lesley Rawlinson;Ferdinand V. Lali;Theresa H. Page

  308
  Citations

• Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

  Jan Bondeson;Brian Foxwell;Fionula Brennan;Marc Feldmann

  301
  Citations

• Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

  Irina A. Udalova;Anna Richardson;Agnes Denys;Clive Smith

  301
  Citations

• Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis.

  Stefan K Drexler;Philip L Kong;Jeremy Wales;Brian M Foxwell

  288
  Citations

• Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP

  Evangelos Andreakos;Sandra M. Sacre;Clive Smith;Anna Lundberg

  277
  Citations